Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinoma.

Br J Cancer · 2005 · PMC2361635 · PMID 16136045

Europe PMC DOI

hedged sentences

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

of borderline significanceP =0.10so close (0.05 < p ≤ 0.1)

This difference was of borderline significance ( P =0.10).

also in 1,681 other papers

showed a trendno p-value reported

In conclusion, the outcome of the individual studies differed as the Danish study showed a trend towards benefit in favour of IL-2/HDC, whereas the UK study was negative for all end points.

also in 33,481 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.